Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS

被引：9
|
作者：
Komatsu, Teppei [1 ]
Matsushima, Satoshi [2 ]
Kaneko, Kimihiko [3 ]
Fukuda, Takahiro [4 ]
机构：
[1] Jikei Univ, Sch Med, Dept Neurol, Tokyo, Japan
[2] Jikei Univ, Sch Med, Dept Radiol, Tokyo, Japan
[3] Natl Hosp Org Miyagi Hosp, Dept Neurol, Sendai, Miyagi, Japan
[4] Jikei Univ, Sch Med, Dept Pathol, Div Neuropathol, Tokyo, Japan
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷 / 01期
关键词：
BRAIN;
D O I：
10.1136/jnnp-2018-319235
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：111 / 112
页数：2
相关论文
共 50 条
  • [1] Two cases of anti-MOG associated CNS demyelinating disease.
    Derfuss, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 96 - 97
  • [2] Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
    Di Pauli, Franziska
    Mader, Simone
    Rostasy, Kevin
    Schanda, Kathrin
    Bajer-Kornek, Barbara
    Ehling, Rainer
    Deisenhammer, Florian
    Reindl, Markus
    Berger, Thomas
    CLINICAL IMMUNOLOGY, 2011, 138 (03) : 247 - 254
  • [3] Anti-MOG Antibody in NMO and Other Demyelinating Diseases.
    Sato, Douglas Kazutoshi
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 398 - 398
  • [4] Clinically Isolated Demyelinating Syndrome Associated with Anti-MOG Antibody
    Schmalstieg, William
    NEUROLOGY, 2019, 92 (15)
  • [5] Clinical features in very early-onset demyelinating disease with anti-MOG antibody
    Nishiyama, Masahiro
    Nagase, Hiroaki
    Matsumoto, Masaaki
    Tomioka, Kazumi
    Awano, Hiroyuki
    Tanaka, Tsukasa
    Toyoshima, Daisaku
    Fujita, Kyoko
    Maruyama, Azusa
    Oyazato, Yoshinobu
    Saeki, Keisuke
    Shiraishi, Kazuhiro
    Takada, Satoshi
    Kaneko, Kimihiko
    Takahashi, Toshiyuki
    Nakashima, Ichiro
    Iijima, Kazumoto
    BRAIN & DEVELOPMENT, 2017, 39 (09): : 756 - 762
  • [6] Anti-MOG antibody-positive meningoencephalitis without demyelinating lesions
    Yamane, Tetsuya
    Ueda, Takuya
    Nishiyama, Masahiro
    Hongo, Hiroto
    Ishida, Yusuke
    Maruyama, Azusa
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [7] Relevance of serum anti-MOG antibodies for diagnosis and characterization of CNS demyelinating disorders
    Mariotto, S.
    Ferrari, S.
    Monaco, S.
    Benedetti, M. D.
    Turatti, M.
    Calabrese, M.
    Alberti, D.
    Farinazzo, A.
    Capra, R.
    De Rossi, N.
    Deotto, L.
    Bonora, A.
    Pavone, A.
    Cadaldini, M.
    Polo, A.
    Bianchi, M. R.
    Bombardi, R.
    Cantalupo, G.
    Shanda, K.
    Reindl, M.
    Gajofatto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 88 - 89
  • [8] MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
    Breza, Marianthi
    Koutsis, Georgios
    Tzartos, John S.
    Velonakis, Georgios
    Evangelopoulos, Maria Eleftheria
    Tzanetakos, Dimitrios
    Karagiorgou, Katerina
    Angelopoulou, Georgia
    Kasselimis, Dimitrios
    Potagas, Constantin
    Anagnostouli, Maria
    Stefanis, Leonidas
    Kilidireas, Constantinos
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 67 - 69
  • [9] Extending the spectrum of anti-MOG antibody positive autoimmune inflammatory CNS disease: overlapping demyelinating syndromes in patients with systemic lupus erythematosus
    Probstel, A. -K.
    Thanei, M.
    Erni, B.
    Lecourt, A. -C.
    Branco, L.
    Andre, R.
    Lalive, P.
    Koenig, K.
    Huynh-Do, U.
    Ribi, C.
    Chizzolini, C.
    Kappos, L.
    Trendelenburg, M.
    Derfuss, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 275 - 275
  • [10] Roles of anti-MOG antibodies in demyelinating diseases
    Tomas Olsson
    Nature Reviews Neurology, 2011, 7 : 248 - 249
12345